This project has not set up a SECURITY.md file yet.

This project has not set up a SECURITY.md file yet.

The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

The U.S. National Institutes of Health (NIH) is the largest funder of biomedical research in the world, and its grants create the foundation of basic science knowledge on which major health ...

“Without relief from NIH’s action, these institutions’ cutting-edge work to cure and treat human disease will grind to a halt.” The NIH is the primary source of federal funding for medical ...

The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.

The cancellations place the future of scientific research up in the air with researchers worried that some applicants will miss their window of opportunity to ever receive NIH funding.

Within hours, as word of NIH meeting cancellations pinged across the social media platform Bluesky, she realized that this wasn’t only about the opioid research she would be reviewing ...

Tabak, a dentist and researcher, was appointed as the NIH’s principal deputy director in 2010. His tenure spans four presidential administrations, and includes a nearly two-year stint as the ...

The NIH confirmed Memoli’s appointment to STAT by email, despite freezing external communications. After this story was published, an NIH spokesperson forwarded a statement from him, saying ...

National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...